This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

2 - 4 November 2021
Delivered in GMT time zone
Menu
keyboard_arrow_right

DAY ONE: MORNING PLENARY - GMT (Greenwich Mean Time)

keyboard_arrow_leftSearch & Filter
search

DAY ONE: MORNING PLENARY - GMT (Greenwich Mean Time)

search
10:55 - 11:005 mins
PLENARY - Main Stage ONLY
Welcome to Day One
  • Louisa Maitland - Conference Director, Informa
11:00 - 11:055 mins
PLENARY - Main Stage ONLY
Opening to CTE
    11:05 - 11:3530 mins
    PLENARY - Main Stage ONLY
    Decentralized Trials and the Pandemic
    • Craig Lipset - Founder & Advisor, Clinical Innovation Partners, Co-Chair, Decentralized Trials & Research Alliance (DTRA)
    11:35 - 12:1540 mins
    PLENARY - Main Stage ONLY
    LIVE DUAL DIALOGUE: Post- Covid is this the New Model for Trials Going Forward?
    • Leonard Sacks - Associate Director for Clinical Methodology in the Office off Medical Policy, FDA - Center for Drug Evaluation and Research (CDER)
    • Kenneth Getz - Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine, Founder and Board Chair, CISCRP
    12:15 - 12:4530 mins
    PLENARY - Main Stage ONLY
    Decentralized Clinical Trials
      12:45 - 13:3045 mins
      LIVE Virtual Showcase Hub Networking Tech Tours Roundtables
        13:30 - 14:0030 mins
        PLENARY - Main Stage ONLY
        Lessons Learnt from the Impact of the Pandemic on On-going Trials and Future Directions
        • Khadija Rantell - Senior Statistical Assessor, Medicines and Health Care Products Regulatory Agency (MHRA), UK
        14:00 - 14:3030 mins
        PLENARY - Main Stage ONLY
        CASE STUDY: Moderna COVID-19 Vaccine Efficacy - Lessons Learned from the Pandemic
        • Randall N. Hyer - SVP, Global Medical Affairs, Moderna
        14:30 - 15:0030 mins
        PLENARY - Main Stage ONLY
        Plenary: Spotlight Presentation:
          15:00 - 15:4545 mins
          PLENARY - Main Stage ONLY
          PANEL: COVID-19: Vaccine Trial Execution Strategies and Technology-Enabled Operations
          • Kenneth Getz - Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine, Founder and Board Chair, CISCRP
          • Randall N. Hyer - SVP, Global Medical Affairs, Moderna
          • Kirsty Wydenbach - Senior Medical Assessor and Deputy Unit Manager, Clinical Trials Unit, Medicines and Healthcare Products Regulatory Agency (MHRA)
          15:45 - 16:3045 mins
          LIVE Virtual Showcase Hub Networking Tech Tours Roundtables
            16:30 - 16:355 mins
            Closing Plenary Remarks
              NextDAY TWO
              Filter
              Streams
              Formats
              Choose Day